Understanding cardiovascular risks in young adults born to hypertensive pregnancies
Official title: Cardiovascular Longitudinal the Avon Longitudinal Study of Parents and Children (ALSPAC) Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Run by University of Oxford · NCT05683093 · Data updated 2026-11-12
This study is looking at the heart health of young adults in their 20s and 30s who were born to mothers with high blood pressure during pregnancy to see if it affects their risk of heart problems later on.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 40 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford, Oxfordshire) |
| Status | Recruiting |
| Started | November 17, 2022 |
| Main results expected | March 1, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | January 12, 2023 |
| Trial ID | NCT05683093 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 30 to 40 who were born to hypertensive pregnancies and previously participated in the ALSPAC study.
✕Probably not a fit
Patients who are currently pregnant, lactating, or have significant chronic diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the cardiovascular health of individuals in their 20s and 30s who were born to mothers with hypertension during pregnancy. It seeks to identify the long-term effects of hypertensive pregnancies on blood pressure and heart disease risk in these individuals. By analyzing changes in the heart, blood vessels, and brain, the study hopes to uncover patterns that could predict future cardiovascular issues. The findings may lead to new prevention strategies for early onset heart and blood vessel diseases in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention strategies for cardiovascular diseases in young adults who were born to hypertensive pregnancies.
How similar studies have gone: Previous studies have indicated that understanding the long-term effects of hypertensive pregnancies can reveal significant cardiovascular risks, suggesting this approach has merit.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study * Male or female, aged 30 to 40 years at time of enrolment * Participant previously took part in the ALSPAC study * Able (in the investigator's opinion) and willing to comply with all study requirements * Adequate understanding of verbal and written English Exclusion Criteria: * Pregnant or lactating when they are due to attend for study visit 1 * Less than six months postpartum * Planning to donate blood within two weeks prior to study visit 1 * Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study * Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status For exclusion of MRI component only: * Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study
Where it's running
-
University of Oxford
Oxford, Oxfordshire, United Kingdom Recruiting
Study contacts
- Principal investigator: Adam J Lewandowski — Cardiovascular Clinical Research Facility
- Study coordinator: Katie Suriano
- Email: clarity@cardiov.ox.ac.uk
- Phone: 01865 226845
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
RADIANCE CED: long-term outcomes after ultrasound renal denervation
This project will see if ultrasound renal denervation (using the Paradise system) lowers blood pressure over the long term in Medicare-age adults (65+) with uncontrolled hypertension by using their medical records.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Long-term outcomes of Symplicity renal denervation for uncontrolled hypertension in Medicare patients
This project will see if adding the Symplicity renal denervation procedure to usual care lowers blood pressure over two years in Medicare patients with uncontrolled hypertension.
-
Streamlined renal denervation with Spyral for uncontrolled high blood pressure
This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.
-
Spyral InSight: renal nerve stimulation before and after renal denervation
This study will test whether stimulating the nerves of the kidney before and after renal denervation is safe and how it changes blood pressure in adults 20–70 with moderately uncontrolled hypertension on 1–3 medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.